Acute Ischemic Stroke Clinical Trial
Official title:
Physical Activity Immediately After Acute Cerebral Ischemia: Too Little or Too Much
Stroke is the leading cause of adult disability in Europe and United States and the second
leading cause of death worldwide and affects more than 10,000 Danes each year.
Studies in a late and stationary phase after stroke have shown that physical rehabilitation
is of great importance for survival and physical ability of these patients, however many
studies show that patients lie or sit next to their bed under hospitalization for more than
88.5 % of the daily hours. Physical activity in stroke patients has never previously been
measured immediately after debut of symptoms; furthermore there is no knowledge about the
optimal dose of physical rehabilitation for these patients.
Accelerometers, small measuring devices, are a relatively new way to measure physical
activity precisely, and hence it is possible to obtain an objective measure of how active
stroke patients are in the first week after admission. The accelerometers measure a variable
voltage, depending on the range and intensity of movement. They can measure movement
dependent of the placement of the accelerometer, for instance over the hip, arm or leg.
Studies confirm their reliability, even in patients with abnormal gait, such as stroke
patients.
Another approach of studying the effects of physical activity and rehabilitation is through
the examination of biomarkers. Studies have shown that biomarkers released during physical
activity can inhibit biomarkers released after tissue injury in the brain, as seen after
stroke. These brain biomarkers cause further damage and studies show that the higher the
levels, the higher the damage. It is therefore obvious to examine whether physical activity
rehabilitation can down regulate this destructive process in patients with stroke.
Clarification of the optimal dose of physical activity in stroke patients immediately after
debut of symptoms and examination of both the biochemical aspects of physical rehabilitation
as well as the optimal dose of physical rehabilitation is of great importance for many
patients, their relatives as well as of a great socioeconomic importance.
The purpose of the project is to investigate feasibility of treadmill training on a
weight-bearing treadmill in the acute phase after admission after an ischemic stroke.
Furthermore we wish to investigate the acute inflammatory response after ischemic stroke and
whether it changes with treadmill training.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | August 2013 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients admitted with acute ischemic stroke - age > 18 years - first stroke or only minor invalidity from previous strokes (mRS 0-2) - truncal stability - SSS score for arm and leg: 10 out of 12 points Exclusion Criteria: - symptoms attributable to other diseases than ischemic stroke - debut of symptoms > 48 h prior to admission - consent not given < 24 h of admission - pregnancy or lactation - isolation - blood sampling generally not possible - allergy due to accelerometer wear - ulcers or other skin diseases in the area of accelerometer placement - unstable cardiologic condition (AMI etc.) - acute high and sustained resting systolic blood pressure where treatment is necessary - acute heart rhythm disorder where treatment is necessary - unable to cooperate - significant orthopedic conditions (fractures etc.) |
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Denmark | Hillerød Hospital | Hillerød |
Lead Sponsor | Collaborator |
---|---|
Hillerod Hospital, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Level of inflammation, under, during and after treadmill training | Biomarker concentration: Interleukin (IL)-6, IL-1beta, Tumor Necrosis Factor(TNF)-alpha, C-Reactive Protein (CRP), IL-1ra, IL-10, fasting-insulin, fasting-glucose | up to 5 days | No |
Secondary | Correlation of biomarker level | Correlation with time, activity counts on an accelerometer, Scandinavian Stroke Scale Score (SSS), National Institutes of Health Stroke Scale score (NIHSS), Glasgow Coma Scale (GCS), Barthels Index-100 (BI), 10 Meters Walking Test (10MWT), modified Rankin Scale (mRS), Assessment of Motor and Process Skills (AMPS), Bergs Balance test, age, Body Mass Index and sex | up to 5 days | No |
Secondary | Feasibility | Whether it is feasible/possible to train patients on a treadmill in the acute phase after ischemic stroke; eg. whether patients are too exhausted to train twice daily, experience complications during training such as nausea or dizziness and therefore can't complete the training programme. | up to 5 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06113848 -
Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy
|
Phase 3 | |
Completed |
NCT04069546 -
The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency
|
N/A | |
Active, not recruiting |
NCT05700097 -
Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
|
Phase 2 | |
Recruiting |
NCT06058130 -
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
|
N/A | |
Recruiting |
NCT04415164 -
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
|
Phase 4 | |
Recruiting |
NCT05363397 -
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
|
Phase 2 | |
Completed |
NCT05429658 -
Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System
|
N/A | |
Recruiting |
NCT05390580 -
Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct
|
N/A | |
Enrolling by invitation |
NCT05515393 -
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
|
Phase 2 | |
Active, not recruiting |
NCT05070260 -
ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
|
Phase 2/Phase 3 | |
Terminated |
NCT05547412 -
Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke
|
||
Completed |
NCT03366818 -
New Stent Retriever, VERSI System for AIS
|
N/A | |
Not yet recruiting |
NCT06437431 -
Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05293080 -
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
|
Phase 3 | |
Not yet recruiting |
NCT06040476 -
Human Umbilical Cord Blood Infusion in Patients With Acute Ischemic Stroke (AIS)
|
Phase 2 | |
Completed |
NCT02223273 -
Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke)
|
N/A | |
Completed |
NCT02586233 -
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT01594190 -
Physical Activity Immediately After Acute Cerebral Ischemia
|
N/A | |
Terminated |
NCT01694381 -
Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
|
Early Phase 1 | |
Completed |
NCT01120301 -
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
|
Phase 3 |